Our aim was to report the clinical experience with combination treatment using tacrolimus and either azathioprine (AZA) or 6-mercaptopurine (6MP) in patients with Crohn's disease (CD) perianal fistulae. The medical records of all patients with Crohn's disease perianal fistulae seen at the Mayo Clini
The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn’s disease
✍ Scribed by Hiroyuki Tamaki; Hiroshi Nakase; Minoru Matsuura; Satoko Inoue; Sakae Mikami; Satoru Ueno; Norimitsu Uza; Hiroshi Kitamura; Katsuhiro Kasahara; Tsutomu Chiba
- Publisher
- Springer Japan
- Year
- 2008
- Tongue
- English
- Weight
- 192 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. in crohn's disease (cd) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. ## Methods: A total of 132
## Background: Fistulas are a common complication of crohn's disease (cd) and are difficult to treat effectively. this study aimed to assess the effects of fistula on annual costs of healthcare and resource utilization for patients with cd. ## Methods: A retrospective analysis, using the pharmetr